LENZ Therapeutics

LENZ

Insider trades and stock quote 2024-2026

All insider trades at LENZ Therapeutics

Subscribe RSS
Date Type Insider Position Ø-Price Volume
3/27/2026 Buy Chevallard, Daniel R. Chief Financial Officer $8.6 $64,275
3/27/2026 Buy Schimmelpennink, Evert B. President, CEO and Secretary $9.0 $251,411
3/27/2026 Buy George, Jeffrey P. Director $8.9 $49,890
11/17/2025 Sell Olsson, Shawn Chief Commercial Officer $26.0 $261,023
11/7/2025 Buy Chevallard, Daniel R. Chief Financial Officer $22.7 $50,017
11/7/2025 Buy Mccollum, James W. Director $22.8 $239,278
9/30/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $46.3 $10,352,017
9/18/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $42.6 $5,714,356
8/26/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $39.2 $2,762,545
8/25/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $39.7 $3,093,626
8/22/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $40.3 $1,567,749
8/18/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $38.6 $1,762,743
8/15/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $39.5 $8,492,501
7/10/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $34.0 $6,506,784
6/27/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $30.5 $6,093,000
6/20/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $30.3 $7,112,818
6/18/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $30.0 $2,995,000
6/10/2025 Sell Versant Venture Capital Vi, L.p. Ten Percent Owner $29.0 $10,150,000
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)